Comparison
1q24q25 Microdeletion Syndrome Cn252652 vs 14q24 1q24 3 Microdeletion Syndrome C4750911
Clinical comparison between 1q24q25 Microdeletion Syndrome CN252652 and 14q24 1q24 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
1q24q25 Microdeletion Syndrome Cn252652
A genetic condition involving deletion of material from chromosome 1. Leads to developmental delays, growth issues, and various medical concerns. Treatment addresses individual symptoms.
14q24 1q24 3 Microdeletion Syndrome C4750911
A rare genetic deletion involving part of chromosome 14. It can affect development and lead to various medical issues. Management focuses on supportive care and addressing specific needs.
6 comparison axes
Onset
1q24q25 Microdeletion Syndrome Cn252652
Variable
14q24 1q24 3 Microdeletion Syndrome C4750911
0-null
Onset patterns differ
Severity
1q24q25 Microdeletion Syndrome Cn252652
severe
14q24 1q24 3 Microdeletion Syndrome C4750911
moderate
Different severity levels
Chronic
1q24q25 Microdeletion Syndrome Cn252652
Chronic
14q24 1q24 3 Microdeletion Syndrome C4750911
Chronic
Differing course
Communicable
1q24q25 Microdeletion Syndrome Cn252652
No
14q24 1q24 3 Microdeletion Syndrome C4750911
No
Different transmission
Body System
1q24q25 Microdeletion Syndrome Cn252652
congenital
14q24 1q24 3 Microdeletion Syndrome C4750911
congenital
Same/different system
Category
1q24q25 Microdeletion Syndrome Cn252652
rare-disease
14q24 1q24 3 Microdeletion Syndrome C4750911
genetic
Different category
Bottom line
1q24q25-microdeletion-syndrome-CN252652 and 14q24-1q24-3-microdeletion-syndrome-C4750911 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q24q25 Microdeletion Syndrome Cn252652 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a possible effect of chromosome 1 material loss. | Development may be affected, but specific pattern is not established. | Low |
| Growth concerns | Growth issues are mentioned in the source description. | Growth effects are not specifically established by the supplied source. | Moderate |
| Overall clinical severity | Source severity is labeled severe. | Source severity is labeled moderate. | Moderate |
When to favor each condition
Choose 1q24q25 Microdeletion Syndrome Cn252652 when
A chromosomal microarray identifies a 1q24q25 deletion.
The genomic location supports the left concept rather than a chromosome 14 deletion.
High
Growth issues accompany developmental delay.
Growth concerns are specifically mentioned for the left condition.
Low
Clinician documents a severe congenital presentation.
This matches the supplied severity label, but severity alone is not diagnostic.
Low
Choose 14q24 1q24 3 Microdeletion Syndrome C4750911 when
Testing shows deletion within 14q24.1-q24.3.
The chromosome 14 interval distinguishes it from a 1q24q25 deletion.
High
A moderate congenital genetic condition is recorded.
This aligns with the supplied severity label but requires genomic confirmation.
Low
Onset timing is unclear in available records.
The supplied right-side onset value is not interpretable and should not be assumed.
Low
How key tests differ
| Test | 1q24q25 Microdeletion Syndrome Cn252652 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 1q24q25 may be detected. | Deletion involving 14q24.1-q24.3 may be detected. | Genomic location is the main discriminator; clinician review is required. |
| Karyotype | May miss a small deletion; no specific result is established. | May miss a small deletion; no specific result is established. | A normal karyotype does not exclude either microdeletion. |
| Developmental assessment | May document delay or growth concerns. | May document developmental effects of unspecified type. | Assessments support care but cannot identify the chromosome involved. |
Prognosis comparison
1q24q25 Microdeletion Syndrome Cn252652
- Outcome
- Long-term outcome is not established; source labels it severe and chronic.
- Factors
- Developmental delay, growth issues, and other individual medical needs may influence care.
14q24 1q24 3 Microdeletion Syndrome C4750911
- Outcome
- Long-term outcome is not established; source labels it moderate and chronic.
- Factors
- Developmental effects and unspecified medical issues may influence needs.
Time frame: No reliable time frame is established from the supplied data.
Genomic findings and individual clinical assessment should guide interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Delays are described and may require individualized support. Development can be affected; exact needs are not established. Neither source defines a uniform complication profile. |
| Growth-related concerns | Growth issues are mentioned. Not specifically established in the supplied description. Monitoring should be individualized rather than assumed. |
| Other medical concerns | Various concerns are possible, without a specified list. Various issues are possible, without a specified list. Complication risk and frequency are not established here. |
Patient education highlights
- HighGenetic confirmation
The chromosome and deleted interval, confirmed by qualified testing, distinguish these conditions.
- HighIndividualized care
Management is supportive and directed to each person's identified needs.
- MediumLimits of comparisons
Severity labels do not predict exact symptoms, complications, or prognosis.